Ticker brief
RLAY RELAY THERAPEUTICS INC
Consumer, Non-cyclical · Biotechnology
last close
$18.65
1 day
+5.0%
14 days
+17.4%
mkt cap
$4.1B
signals 14d
5
authors 14d
4
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-07-01 · now +0.40 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @PersimmonTI | A | -0.32 | 2 | -0.38 |
| @Stockspy1 | C | +0.01 | 1 | +0.12 |
| @equitydd | C | +0.19 | 1 | +0.25 |
| @Speculator_io | B | +0.06 | 1 | +0.40 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-01 | @Speculator_io | +0.40 | Calls biotech one of strongest sectors outside AI and lists subsector baskets; first six tickers retained due cap. | +5.0% | tweet ↗ |
| 2026-06-28 | @PersimmonTI | -0.55 | Long CELC / short RLAY would be interesting. — Author frames long CELC and short RLAY as interesting pair trade. | +0.5% | tweet ↗ |
| 2026-06-27 | @equitydd | +0.25 | Biotech watchlist for upcoming catalysts and long-term growth potential. | +0.5% | tweet ↗ |
| 2026-06-27 | @PersimmonTI | -0.20 | Questions relative valuations of RLAY at $4B and CELC at $4.9B. | +0.5% | tweet ↗ |
| 2026-06-22 | @Stockspy1 | +0.12 | Says no position and no plan to enter RLAY while biotechs bid up. | +7.9% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.